SummarySystolic anterior motion (SAM) of the mitral valve after aortic valve replacement (AVR) for severe aortic stenosis (AS) is one of the causes of perioperative left ventricular outflow tract (LVOT) obstruction in older patients. A 90-yearold woman underwent AVR with a 19-mm bioprosthesis for symptomatic aortic valve stenosis. Preoperative transthoracic echocardiography (TTE) showed left ventricular hypertrophy, with LVOT obstruction and mild mitral regurgitation (MR). Intraoperative transesophageal echocardiography and postoperative TTE showed that the degree of MR was unchanged after surgery. The patient's postoperative course was uneventful. However, she developed shortness of breath 6 months after discharge. A subsequent TTE showed significant LVOT obstruction and SAM, which resulted in moderate to severe MR. Because of the patient's advanced age, cibenzoline was administered to decrease the left ventricular pressure gradient (LVPG) and improve the left ventricular diastolic function. Two months after administration of cibenzoline, a TTE showed decreased LVPG, trivial MR, and the absence of SAM. This case clearly demonstrated that cibenzoline improved the SAM of the mitral valve that arose after AVR for AS in a remote postoperative period. ( 1-3) However, such patients rarely present with clinical symptoms. Therefore, therapy for the reduction of left ventricular pressure gradient associated with SAM has not been established. Although several reports have described this phenomenon, all of the cases were early onset, such as during the intraoperative and hospitalization periods. [4][5][6][7][8] Here, we report a case of delayed-onset SAM, after AVR leading to cardiac insufficiency that was managed with cibenzoline.
Case ReportA 90-year-old woman (weight, 41.8 kg; height, 144 cm), who had complained of shortness of breath and palpitations due to severe AS, was referred to our hospital for AVR. Transthoracic echocardiography (TTE) showed a calcified, immobile aortic valve with peak and mean pressure gradients of 129 and 82 mmHg, respectively. The left ventricular (LV) end-diastolic and systolic diameters were 37 and 20 mm, respectively, with an ejection fraction (EF) of 78%. During diastole, the thickness of the interventricular septum was 16 mm and that of the posterior wall was 14 mm. The left ventricle showed secondary hypertrophy with a significant LVOT pressure gradient of 20 mmHg. Mitral regurgitation (MR) was mild, and no significant SAM was observed. Angiography showed normal coronary arteries.During AVR, her heavily calcified leaflet was removed and replaced with a 19-mm Carpentier-Edwards Perimount Magna aortic bioprosthesis (Edwards LifeSciences, Irvine, CA, USA), with supra-annular placement in the aortic position. Intraoperative transesophageal echocardiography, performed before weaning from cardiopulmonary bypass (CPB), showed mild MR and the absence of significant obstruction of the LVOT (Figure 1). Thus, weaning from CPB was uneventful. Surgery was completed without any complications. The pa...